Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

A research study comparing different ways of increasing the dose of NNC0519-0130 in participants with overweight or obesity Ended

2023-508940-23-01 Type 2 diabetes mellitus 2025-02-21
A randomised, double-blind, placebo-controlled trial to assess the effects of EP395 following an inhaled endotoxin challenge in healthy adul… Ended

2024-516187-29-00 Healthy volunteers [targeted indication: chronic obstru 2025-02-20
A Phase Ib, Multicentre, Randomised, Single-blind, Parallel-group, Placebo-controlled, Study to Characterise the Pharmacokinetics and Pharma… Ended

2024-516474-30-00 Asthma 2025-02-19
Drug-Drug Interaction between Empagliflozin 25 mg Film-Coated Tablets and Alogliptin 25 mg Film-Coated Tablets in Healthy Participants Under… Ended

2025-520459-10-00 No medical condition. 2025-02-18
Drug-Drug Interaction between Alogliptin 25 mg Film-Coated Tablets and Empagliflozin 25 mg Film-Coated Tablets in Healthy Participants Under… Ended

2025-520460-18-00 No medical condition. 2025-02-18
A Mass Balance Study of [14C]-IPN60250 in Healthy Adult Participants Ended

2024-515195-12-00 Primary sclerosing cholangitis (PSC) 2025-02-18
Randomized, open-label clinical trial (Phase 1) to evaluate safety, tolerability, pharmacokinetics and food effects of a single dose of IM-2… Ended

2024-518155-37-00 Healthy volunteers 2025-02-14
A Randomized, Four-Way Change-over Study to Evaluate the Effect of Moderate Heat, Occlusion, and Moderate Exercise on the Pharmacokinetics a… Ended

2024-513059-33-00 bioavailability trial with healthy volunteers, therapeu 2025-02-12
Study on the investigational drug SAN711, placebo-controlled, administered to healthy adults and elderly subjects at multiple ascending oral… Ended

2024-514514-12-00 Absence Seizure 2025-02-12
A PHASE 1B DOSE RANGE FINDING STUDY OF PHENSERINE COMPARED TO DONEPEZIL IN PARTICIPANTS WITH EARLY OR MILD ALZHEIMER’S DISEASE Ended

2023-510282-10-00 Mild Cognitive Impairment 2025-02-11
A single center, open-label pilot study in healthy subjects using dermal open flow microperfusion to collect body fluids for bioanalytical m… Ended

2024-515780-62-00 No medical condition is being investigated in this clin 2025-02-05
Testing Insulin Enemas for Ulcerative Colitis: A First-Stage Clinical Trial Ended

2023-510335-11-00 Ulcerative colitis 2025-02-04
A study to learn about how itraconazole affects the level of emodepside in the blood when emodepside is given as a new type of tablet to hea… Ended

2024-515757-24-00 Soil-transmitted helminth infection 2025-02-04
Study of Repotrectinib and CYP450 probe Cocktail in Patients with locally advanced or Metastatic Tyrosine Kinase Inhibitors (TKI)-Pretreated… Ended

2024-511030-12-00 Non-small Cell Lung Cancer (NSCLC) 2025-02-03
A study in healthy people to compare how 3 different formulations of survodutide are taken up in the body Ended

2024-516529-30-00 Healthy volunteer trial 2025-01-31
An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporo… Ended

2024-514496-18-01 Hepatocellular carcinoma, renal cell carcinoma and diff 2025-01-30
A study to test how insulin NNC0471-0119 H works in the body in participants with type 1 diabetes when given by an insulin pump. Ended

2024-513472-18-00 Diabetes mellitus type 1 2025-01-23
A clinical study of MK-2828 in healthy people (MK-2828-002) Ended

2024-518229-13-00 Atherosclerosis 2025-01-21
A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of AZD8630, Administered Once Daily via Inhalation, for 2 Weeks, in Adu… Ended

2024-514213-35-00 Asthma 2025-01-20
A study in healthy people to test whether BI 1291583 influences the amount of dabigatran in the body Ended

2024-516256-18-00 Healthy volunteer trial 2025-01-20
Ceftobiprole OATP1B interaction study Ended

2024-518592-60-00 Community-acquired bacterial pneumonia 2025-01-17
A bioavailability study of epinephrine following a single dose of emergency response auto-injector in comparison to epinephrine injection in… Ended

2024-516575-32-00 Allergic reactions (Type 1), including anaphylaxis, idi 2025-01-10
A Study Evaluating the Pharmacokinetics of Three QRL-101 Formulations in Healthy Participants Ended

2024-518833-27-00 Amyotrophic Lateral Sclerosis (ALS) 2025-01-10
M9466 in Combination with Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511) Ended

2024-514155-15-00 Advanced solid tumors and colorectal cancer 2025-01-08